Vera Bittner

Overview

Best Publications

• Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)

  Stephen Hulley;Curt Furberg;Elizabeth Barrett-Connor;Jane Cauley

  2448
  Citations

• Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association

  Michael Miller;Neil J. Stone;Christie Ballantyne;Vera Bittner

  2251
  Citations

• HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events

  Philip Barter;Antonio M. Gotto;John C. LaRosa;Jaman Maroni

  2075
  Citations

• Exercise Standards for Testing and Training A Scientific Statement From the American Heart Association

  Gerald F. Fletcher;Philip A. Ades;Paul Kligfield;Ross A. Arena

  2049
  Citations

• Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation.

  Gary J. Balady;Mark A. Williams;Philip A. Ades;Vera Bittner

  1638
  Citations

• Resistance Exercise in Individuals With and Without Cardiovascular Disease: 2007 Update A Scientific Statement From the American Heart Association Council on Clinical Cardiology and Council on Nutrition, Physical Activity, and Metabolism

  Mark A. Williams;William L. Haskell;Philip A. Ades;Ezra A. Amsterdam

  1569
  Citations

• Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators

  Vera Bittner;Debra H. Weiner;Salim Yusuf;William J. Rogers

  1304
  Citations

• Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease.

  C. Noel Bairey Merz;Leslee J. Shaw;Steven E. Reis;Vera Bittner

  1162
  Citations

• The 6-min Walk Test: A Quick Measure of Functional Status in Elderly Adults

  Paul L. Enright;Mary Ann McBurnie;Vera Bittner;Russell P. Tracy

  1080
  Citations

• Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.

  Leslee J. Shaw;C. Noel Bairey Merz;Carl J. Pepine;Steven E. Reis

  957
  Citations

• Effects of hormone replacement therapy and antioxidant Vitamin supplements on coronary atherosclerosis in postmenopausal women: A randomized controlled trial

  David D. Waters;Edwin L. Alderman;Judith Hsia;Barbara V. Howard

  719
  Citations

• Referral, Enrollment, and Delivery of Cardiac Rehabilitation/Secondary Prevention Programs at Clinical Centers and Beyond A Presidential Advisory From the American Heart Association

  Gary J. Balady;Philip A. Ades;Vera A. Bittner;Barry A. Franklin

  718
  Citations

• Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

  Laxmi S. Mehta;Karol E. Watson;Ana Barac;Theresa M. Beckie

  661
  Citations

• Population Approaches to Improve Diet, Physical Activity, and Smoking Habits: A Scientific Statement From the American Heart Association

  Dariush Mozaffarian;Ashkan Afshin;Neal L. Benowitz;Vera Bittner

  624
  Citations

• Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.

  Alka M. Kanaya;David Herrington;Eric Vittinghoff;Feng Lin

  624
  Citations

• Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

  Gregory G. Schwartz;Laurence Bessac;Lisa G. Berdan;Deepak L. Bhatt

  538
  Citations

• Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease.

  Jill A. Bennett;Barbara Riegel;Vera Bittner;Joyce Nichols

  525
  Citations

• Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival : Results from the National Institutes of Health-National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation

  Leslee J. Shaw;C. Noel Bairey Merz;Ricardo Azziz;Frank Z. Stanczyk

  462
  Citations

• Glycemic effects of postmenopausal hormone therapy: the heart attack and estrogen/progestin replacement study. A randomized, double-blind, placebo-controlled trial☆

  A.M. Kanaya;D. Herrington;E. Vittinghoff

  2
  Citations

• Exercise Standards for Testing and Training: A Scientific Statement From the American

  Jonathan Rhodes;Paul D. Thompson;Mark A. Williams;Lola A. Coke

  1
  Citations